9 Results

People

  1. Scher
    Scher
  2. Morris
    Morris
  3. Rathkopf
    Rathkopf
  4. Abida
    Abida
  5. Schultz
    Schultz
  6. Danila
    Danila
  7. Gopalan
    Gopalan
  8. Kantoff
    Kantoff
  9. Slovin
    Slovin
  10. Solit
    Solit

Groups

  1. Department of Medicine (9)
  2. Genitourinary Oncology Service (9)
  3. Solid Tumor Oncology Division (9)
  4. Computational Oncology Service (4)
  5. Epidemiology and Biostatistics (4)
  6. GSK Faculty (4)
  7. Hematologic Malignancies, Division of (4)
  8. Human Oncology and Pathogenesis Program (4)
  9. Sloan Kettering Institute Postdocs (3)
  10. Center for Hematologic Malignancies (2)
  1. "priority journal"
  2. "Howard Scher"
  3. "Dana Rathkopf"
Formats
  1. Journal Article (9)
Groups
  1. Department of Medicine (9)
  2. Genitourinary Oncology Service (9)
  3. Solid Tumor Oncology Division (9)
  4. Computational Oncology Service (4)
  5. Epidemiology and Biostatistics (4)
  6. GSK Faculty (4)

More Groups

People
  1. Dana Rathkopf (9)
  2. Howard Scher (9)
  3. Michael Morris (5)
  4. Nikolaus Schultz (4)
  5. Philip Kantoff (4)
  6. Wassim Abida (4)

More People

Years
  1. 2020 (2)
  2. 2018 (1)
  3. 2017 (1)
  4. 2016 (1)
  5. 2015 (3)
  6. 2014 (1)
Publications
  1. European Urology (3)
  2. JCO Precision Oncology (2)
  3. Annals of Oncology (1)
  4. Cell (1)
  5. Clinical Cancer Research (1)
  6. New England Journal of Medicine (1)
Publishers
  1. Elsevier Science, Inc. (3)
  2. American Society of Clinical Oncology (2)
  3. American Association for Cancer Research (1)
  4. Cell Press (1)
  5. Massachusetts Medical Society (1)
  6. Oxford University Press (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pan-cancer analysis of CDK12 alterations identifies a subset of prostate cancers with distinct genomic and clinical characteristics
    Journal Article

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H. I.; Kantoff, P. W.; Gopalan, A.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Platinum-based chemotherapy in metastatic prostate cancer with DNA repair gene alterations
    Journal Article

    Mota, J. M.; Barnett, E.; Nauseef, J. T.; Nguyen, B.; Stopsack, K. H.; Wibmer, A.; Flynn, J. R.; Heller, G.; Danila, D. C.; Rathkopf, D.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Naming disease states for clinical utility in prostate cancer: A rose by any other name might not smell as sweet
    Journal Article

    Armstrong, A. J.; Antonarakis, E. S.; Taplin, M. E.; Kelly, W. K.; Beltran, H.; Fizazi, K.; Dahut, W. L.; Shore, N.; Slovin, S.; George, D.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Journal Article

    Abida, W.; Armenia, J.; Gopalan, A.; Brennan, R.; Walsh, M.; Barron, D.; Danila, D.; Rathkopf, D.; Morris, M.; Slovin, S.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Low incidence of corticosteroid-associated adverse events on long-term exposure to low-dose prednisone given with abiraterone acetate to patients with metastatic castration-resistant prostate cancer
    Journal Article

    Fizazi, K.; Chi, K. N.; de Bono, J. S.; Gomella, L. G.; Miller, K.; Rathkopf, D. E.; Ryan, C. J.; Scher, H. I.; Shore, N. D.; De Porre, P.; more...
    European Urology (2016)

    Fulltext@MSK | Save
  • Impact of bone-targeted therapies in chemotherapy-naïve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: Post hoc analysis of study COU-AA-302
    Journal Article

    Saad, F.; Shore, N.; Van Poppel, H.; Rathkopf, D. E.; Smith, M. R.; de Bono, J. S.; Logothetis, C. J.; De Souza, P.; Fizazi, K.; Mulders, P. F. A.; more...
    European Urology (2015)

    Fulltext@MSK | Save
  • Integrative clinical genomics of advanced prostate cancer
    Journal Article

    Robinson, D.; Van Allen, E. M.; Wu, Y. M.; Schultz, N.; Lonigro, R. J.; Mosquera, J. M.; Montgomery, B.; Taplin, M. E.; Pritchard, C. C.; Attard, G.; more...
    Cell (2015)

    Fulltext@MSK | Save
  • Improvements in radiographic progression-free survival stratified by ERG gene status in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate
    Journal Article

    Attard, G.; de Bono, J. S.; Logothetis, C. J.; Fizazi, K.; Mukherjee, S. D.; Joshua, A. M.; Schrijvers, D.; Van Den Eertwegh, A. J. M.; Li, W.; Molina, A.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Enzalutamide in metastatic prostate cancer before chemotherapy
    Journal Article

    Beer, T. M.; Armstrong, A. J.; Rathkopf, D. E.; Loriot, Y.; Sternberg, C. N.; Higano, C. S.; Iversen, P.; Bhattacharya, S.; Carles, J.; Chowdhury, S.; more...
    New England Journal of Medicine (2014)

    Fulltext@MSK | Save